fig1

Liquid biopsy-based technologies: a promising tool for biomarker identification in her2-low breast cancer patients for improved therapeutic outcomes

Figure 1. The image visually represents breast cancer classification based on molecular biology. It highlights different molecular subtypes of breast cancer, such as HER2-positive and hormone receptor-positive tumors. The bottom bar showcases various diagnostic tools, including traditional tissue biopsies, immunohistochemistry, liquid biopsy techniques like ctDNA and CTC analysis, and RNA-based screening methods. The image emphasizes the role of molecular profiling in guiding personalized treatment strategies for breast cancer patients. Image created with Biorender.com.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/